Willis Towers Watson Public Limited Company (WTW) Earnings Call Transcript & Summary
October 29, 2026
What were the key takeaways from Willis Towers Watson Public Limited Company's October 29, 2026 earnings call?
In the third quarter of fiscal year 2026, Willis Towers Watson (WTW) reported a 4% organic revenue growth, with adjusted EPS rising 18% to $3.63. The company experienced adjusted operating margin expansion of 150 basis points to 21.9%. Management has adjusted its full-year organic growth outlook to low to mid-single-digit growth, primarily due to delays in the Benefits Delivery & Outsourcing segment, which is now expected to be flat for the year. Despite these challenges, the company remains confident in its strategic initiatives and technology investments, particularly its Propel AI Acceleration Plan, which is expected to drive further margin improvements and operational efficiencies going forward.
What topics did Willis Towers Watson Public Limited Company cover?
- Revenue Growth Performance: WTW achieved 4% organic revenue growth in Q3 2026, with Health, Wealth & Career (HWC) and Risk & Broking (R&B) segments contributing positively. HWC grew 4% organically, while R&B reported a 5% organic growth, driven by strong performance in North America. Management stated, "Across both segments, we grew the top line and expanded margins, allowing us to deliver double-digit earnings growth."
- Adjusted EPS Growth: The company reported an 18% increase in adjusted EPS to $3.63, reflecting strong expense discipline and top-line momentum. Andrew Krasner noted, "These results reflect healthy top line momentum early benefits of the technology investments..."
- Guidance Adjustment: Management revised its full-year organic growth outlook to low to mid-single-digit growth, down from mid-single-digit expectations. This adjustment is primarily due to delays in the Benefits Delivery & Outsourcing segment, which is now expected to be flat for 2026. Carl Hess mentioned, "We've adjusted our full year outlook to low to mid-single-digit growth, mainly because of the implementation timing of BD&O."
- Technology Investments and Propel Plan: WTW's Propel AI Acceleration Plan is expected to enhance operational efficiency and drive margin improvements. The company aims for an adjusted operating margin of approximately 30% by 2028, with Carl Hess stating, "Propel gives us a clear path to an adjusted operating margin of approximately 30% in 2028."
- Market Conditions and Pricing Environment: Management noted a competitive pricing environment with softening commercial insurance rates, particularly in property segments. However, they remain confident in their specialization strategy to navigate these challenges. Carl Hess commented, "We do not try to predict the market. We stay focused on our proven strategy of specialization, data and analytics..."
What were Willis Towers Watson Public Limited Company's October 29, 2026 results?
- Organic Revenue Growth: 4%
- Adjusted EPS: $3.63 (+18% YoY)
- Adjusted Operating Margin: 21.9% (+150 basis points YoY)
- Health, Wealth & Career Organic Growth: 4%
- Risk & Broking Organic Growth: 5%
- Benefits Delivery & Outsourcing Organic Growth: -2%
WTW's third-quarter results reflect solid operational performance but highlight challenges in specific segments that may impact future growth. The company's strategic focus on technology and AI through the Propel initiative positions it well for long-term margin expansion. Investors should monitor the execution of Propel, the impact of market conditions on growth, and the company's ability to navigate delays in key segments.
Earnings Call Speaker Segments
Carl Hess
executiveThanks, Claudia, and good morning, everyone. We appreciate you being with us for WTW's earnings call covering the third quarter of 2026. With me today is Andrew Krasner, our Chief Financial Officer. Also here for our Q&A session are Julie Gebauer, President of Health, Wealth & Career, and Lucy Clarke, President of Risk & Broking. During the third quarter, we achieved 4% organic growth, adjusted operating margin expansion of 150 basis points, and 18% growth in adjusted EPS. The results for this quarter show how strong and resilient our model is, the ongoing payoff from what we've invested in technology, and our team's dedication both to clients and to keeping costs disciplined. We grew revenue and expanded margins across both segments, producing double-digit earnings growth. R&B delivered 5% organic growth, driven by North America and International, as our strategy continues to generate growth, especially in our global specialty lines. Health, Wealth & Career rose 4%, led by the Health and Career businesses. Our pipeline is showing solid momentum, and we are confident about where we stand as we head into the fourth quarter. We continue to execute our strategy consistently while accelerating technology and AI adoption. I'd like to start today's remarks by updating you on our strategic progress and on the rollout of Propel, the AI acceleration plan we introduced last quarter. Following that, I'll share a few thoughts on the market backdrop, and then Andrew will take you through the results and outlook in more depth. Our strategy — speeding up performance, boosting efficiency, and optimizing the portfolio — continues to generate value even in a turbulent macro environment. The strongest evidence is the business we're capturing, as both new and existing relationships convert into sizable mandates, driven by our know-how, our innovation, and a client delivery model that grows more efficient all the time. I'd like to highlight a handful of wins this quarter that demonstrate how the strategy is landing. Within Health, Wealth & Career, we're seeing robust appetite for our AI-powered products, among them the AI workforce transformation offering. This quarter, a Fortune 500 energy firm picked us to spearhead a broad AI workforce transformation effort, under which we are shaping the skills framework, the operating model, and the company-wide adoption strategy. That piece of work stemmed from our solid ties with the client's leadership, which enabled us to identify the requirement early and establish WTW as a strategic advisor. Forming smart connections continues to be a productive engine of growth for HWC. A major U.S. utility — a retirement and health and benefits client of ours for many years — has expanded its relationship with us. It added full benefits administration covering about 50,000 employees and retirees, a broader Embark deployment, and benefit account administration. We also recorded another notable smart connections win with a rapidly expanding global AI infrastructure firm whose U.S. headcount has increased more than tenfold since January. That firm gave us a seven-figure engagement that includes health and benefits plan management, global benefits governance, our LifeSight pooled employer plan, and employee communications. That relationship already extends beyond HWC and is creating opportunities for our Corporate Risk & Broking business. Within Risk & Broking, specialization keeps delivering wins for us; down in Latin America, our construction team landed a construction all risks and excess liability program for a global medical technology company's new manufacturing facility, and our risk and analytics plus catastrophe modeling capabilities helped us capture the property program for a leading energy group. Those two wins show how powerful it is to pair local relationships with global specialty expertise. With innovation speeding up throughout the defense and security sector, demand keeps rising for specialized risk solutions capable of keeping pace with fast technological development and complicated government procurement requirements. During this quarter, a fast-growing defense technology firm received that expertise from one of our worldwide specialty teams. We helped the company address intricate liability, operational, and personnel risks as it approached a critical testing milestone, and supported its efforts to advance commercial and funding goals. Robust new business momentum keeps building in other specialty lines as well. Earlier this year a global sports and apparel company named us across all lines, and it has already expanded the scope of our engagement — a direct reflection of how swiftly we execute and of our capacity to deliver distinctive specialty expertise to the relationship. Finally, within Insurance Consulting and Technology, one of the world's top insurers expanded its already strong ties with us, rolling out our Radar pricing and underwriting platform to its retail operations internationally. With Radar, the company will sharpen pricing and risk selection across the markets where it operates worldwide — proof that embedding AI more deeply keeps boosting what the platform delivers. In both segments, these wins demonstrate that clients respond well to our approach: cultivating close, trust-based relationships and delivering value via specialized know-how, our own data, and distinctive technology. I'll take a few minutes now to go deeper on that technology point. During the previous quarter, we launched Propel, WTW's plan to accelerate AI. Propel and our wider tech investments bring plenty of advantages, including the chance to set our businesses apart, make our client offering stronger, and generate growth. Our emphasis is on using these capabilities to create new solutions, improve the ones we already have, and serve clients better. A good illustration of innovation is Via Benefits retirement, the solution we launched not long ago, which we see as transformative for people moving out of work and into retirement. Via Benefits retirement draws on our extensive know-how and background in retirement and investments. It pairs advanced AI-powered financial planning assistance with an easy-to-use digital experience and a marketplace offering institutional-grade investment vehicles and annuities at costs below those of the retail market. Via Benefits offers a full retirement journey meant to give people more confidence as they transition out of work—confidence that the savings built up over a career will cover their financial needs. For the corporate clients we serve, that translates into a dependable route for employees entering retirement. And for WTW shareholders, it represents a promising move into a big market that hasn't been well served. To give another example of our AI work, we partnered with Microsoft on an agentic administration process built into Violet, our outsourcing AI suite. That process is running now, managing complete workflows across 160 vendors and more than 20 clients. In practice, that translates to agents taking on vendor exports, HRIS data imports, and case management, while people supply the oversight. The model directs colleagues to the areas of greatest importance — decisions that call for contextual expertise. To date it has saved tens of thousands of human hours, and it additionally establishes the operational foundation for carrying this capability into additional workflows and client programs. To phrase it another way, this represents the start of a fresh operating model for our BD&O businesses. Building on what I said before, our AI workforce transformation offering—rolled out in June—is landing deals with several of the largest US employers. On top of that, in September we unveiled a partnership with Lyzr, a company providing an enterprise agentic AI platform, designed to move clients from planning workforce transformation into actual execution by placing AI agents directly within HR processes.
Carl Hess
executiveIn Insurance Consulting and Technology, we're drawing on our expertise and technological capabilities to assist insurers in embedding AI across pricing, underwriting, portfolio management, and risk modeling — this includes the Radar AI Assistant that we released in September, which lets underwriters and portfolio managers surface emerging risk signals in their data through natural language. AI is also making it simpler for clients to work with us and with their own data; in September, CRB launched RiskIQ Nexus, a risk intelligence platform that pulls a client's policy, premium, loss, and exposure information from multiple sources into one connected view. The AI features can take in documents written in various languages and let risk managers ask questions—and receive answers—about their own programs, such as: What coverage do we have? What's our total cost of risk? Which renewals are coming up? Nexus is able to hold a client's entire program, and our specialists are connected and available to assist clients in understanding and acting on what Nexus brings to light; we're introducing Nexus to clients around the world. Of course, AI is also assisting us in improving efficiency, freeing up more time for our colleagues to focus on what matters, including innovation, client-facing work, and strategic priorities that drive growth. Since we unveiled Propel, we've set up workstreams throughout the company. During the prior quarter's call, I noted that a number of these efforts extend work already underway. With Propel, we have a structured, governed means of speeding up ideas that have proven themselves and extending them throughout WTW. In addition to the efforts I've cited, we are right now putting technology in place that helps our retirement actuarial teams finish valuations more quickly. Within Health, we are expanding automation throughout claims servicing and benefits administration. In CRB, we keep introducing our AI-enabled operating model across broking operations worldwide, tailored to the regulatory and data needs of each region. This covers an AI assistant that our client service and placement colleagues in North America are now using, which helps service teams turn out client-ready documents more quickly and allows brokers to pass off routine analysis and submission work. Alongside that, we currently have multiple AI agents in operation, managing high-volume, rules-based tasks like issuing certificates. Although scaling these benefits will take time, progress is already visible, and we stay confident in the expectations we shared last quarter. Turning to what comes next for the program: Great Britain and North America already have a lot of these capabilities in place within Risk & Broking, and there we'll launch the first global release of Neuron — our AI-enabled operating model — during the fourth quarter. It bundles the complete set of capabilities into one standardized deployment, which brings structure to our implementations worldwide and extends it to 10 more countries throughout Europe and Asia Pacific, with additional countries to come afterward. On the Health, Wealth & Career side, we're moving beyond the foundational phase and into more design and delivery work. To illustrate, AI-powered processes will be integrated for a bigger portion of the clients we serve in benefits administration, and at the start of 2027 our inaugural AI-enabled offering for global actuarial coordination is set to debut. In parallel, within our HWC business the technology groups are adopting AI-native approaches to software development, enabling faster building, testing, and delivery of new products and features. Leveraging the shared data and AI platform groundwork established in 2026, starting in 2027 we will implement operating model enhancements throughout our Wealth and Career businesses. We'll continue to keep you informed on progress as we carry out Propel. Finally, regarding portfolio optimization, the integrations of Newfront and Cushion remain on schedule, and cost synergies are slightly exceeding our plan. We are likewise continuing to make headway with Willis Re—our reinsurance joint venture with Bain Capital—which achieved 2 significant milestones during the third quarter. The first was the appointment of Neil Eckert as CEO; he is set to join Willis Re in early 2027, once he has fulfilled his commitments to his present employer. Neil brings approximately 4 decades of reinsurance broking experience, and he is strongly positioned to guide the business through this next stage of growth. The second was Willis Re's announcement of a deal to purchase BMS Re's US reinsurance broking operations, a move that furthers its strategy for global expansion. The deal, which should be finalized in Q4 assuming regulators sign off, hands Willis Re an instant foothold in the biggest insurance market globally while broadening its reach in appealing specialty lines. Having secured approvals from regulators in the UAE and Bahrain, we additionally acquired complete ownership of Al Futtaim Willis, the Middle East joint venture we have partnered with for years. Alongside the insurance and reinsurance broking operations we established in Saudi Arabia not long ago, this lets customers across the region tap into all of our specialist expertise and worldwide placement resources. On the market side: commercial insurance pricing continued to ease during Q3. Property remained the weakest area, particularly for big and intricate programs, since plentiful capacity and minimal catastrophe losses made competition fiercer. US casualty stood out as the clear exception, with pricing continuing to rise, especially in excess layers, as insurers react to inflation in loss costs. Our approach to this situation mirrors the one that worked well for us in earlier cycles: we avoid attempting to forecast the market; we keep our attention on our established strategy of specialization, data and analytics, and disciplined execution regarding retention and new business. In Corporate Risk & Broking, demand is still especially robust in specialty segments like transactional risk, construction, digital infrastructure, natural resources, defense and security, and sports and entertainment. Beyond that, the trends from recent quarters remain in place. Softening in the labor market has carried on, and Middle East conditions continue to pressure discretionary project work in certain parts of our Career businesses. At the same time, rising healthcare costs, regulatory changes, rapid technological advancement, and greater geopolitical and economic uncertainty are all still driving robust demand for the advice and solutions we provide. Overall, this quarter showed both the resilience of our business model and our disciplined execution. For 2026, we continue to expect mid-single-digit organic growth, albeit toward the lower end of that range, plus ongoing yearly expansion of adjusted operating margin and better free cash flow. In addition, Propel provides us a clear route to an adjusted operating margin of roughly 30% in 2028. With that, I'll hand the call over to Andrew.
Andrew Krasner
executiveThanks, Carl. Good morning, everyone, and I appreciate you joining us. In the third quarter, organic revenue growth was 4%. Adjusted operating margin came in at 21.9%, an expansion of 150 basis points compared with the prior year. Adjusted diluted earnings per share were $3.63, up 18% from the third quarter of 2025. Those results reflect healthy top-line momentum, the early payoff from the technology investments Carl discussed, and firm expense discipline. Turning now to segment results, starting with Health, Wealth & Career, where organic revenue increased 4% in the third quarter, led by Health and Career. Health delivered 6% organic growth, with gains in every region coming from new business, strong renewals, and project work layered on top of our recurring revenue base. Performance outside North America was particularly strong, with Europe and International each posting high single digits or better. For the full year, we continue to expect high single-digit organic growth in Health, supported by strong and sustained demand as employers turn to us to help design, deliver, and manage comprehensive healthcare programs amid elevated healthcare costs. Wealth grew 2% organically, reflecting steady retirement activity in Europe and International plus new client wins around the globe. We continue to expect growth at the high end of the low single-digit range for the full year as recent trends hold, including neutral to slightly positive capital markets and continued de-risking activity, particularly in Great Britain. Career grew 9% organically, or 10% excluding the Middle East, driven mainly by higher sales and delivery of compensation surveys. Some of this quarter's growth came from timing, given the shift in the survey delivery pattern that held back growth in the third quarter of 2025. Taking that timing benefit into account, along with the challenging prior-year comparison and the ongoing headwinds from the Middle East conflict, we are narrowing our Career outlook to low single-digit growth for the full year, down from low to mid-single-digit growth. Benefits Delivery & Outsourcing declined 2% organically. Our outsourcing business grew modestly on new client wins, regulatory-driven activity, and project work, while individual marketplace revenue fell as expected outside the annual enrollment period, which is a fourth quarter event. In individual marketplace, we had our strongest sales cycle in a decade. Even so, several very large clients that had committed to new engagements pushed their implementations into next year. Importantly, since these are only implementation delays, the commitments stand and add to a pipeline for next year that is already strong. As a result, we now expect BD&O revenue to be roughly flat for 2026, compared with our prior expectation of low single-digit growth. At the Health, Wealth & Career level, we now expect low to mid-single-digit organic growth for the full year. That compares with our prior expectation of mid-single-digit growth and reflects both the BD&O implementation delays and the dynamics affecting Career. Free cash flow for the nine months ended September 30 was $1.064 billion, up $226 million from $838 million in the prior year period. At HWC, the operating margin for the third quarter was 29.5%, which represents a 90 basis point increase compared with the same quarter last year. The primary factors behind that were operating leverage and expense discipline, and for the full year we continue to expect margin expansion at HWC. Now moving to Risk & Broking, organic revenue growth in the quarter was 5%. If you exclude book of business settlements and interest income, organic growth was 4%. At Corporate Risk & Broking, organic growth was 5%, or 4% excluding book of business settlements and interest income. North America led the segment with double-digit growth, driven by construction, surety, transactional risk, and strong new business across nearly all of our specialty lines. Our International region delivered high single-digit growth, with particular strength in Asia and in Central and Eastern Europe, the Middle East, and Africa. Europe's results reflected a difficult prior-year comparison that included multiyear project placements we flagged back in the third quarter of last year. Aside from that item, Europe grew modestly. As we said at the time, our specialty businesses — several of which are growing at double-digit rates — contain a mix of recurring and one-off work, and the timing of larger multiyear project placements can create variability in our quarterly growth rates; this dynamic was a headwind to growth in the quarter, and we expect it to ease in the fourth quarter. As Carl noted, pricing remained competitive in the third quarter, with insurance rates continuing to decline across most lines. Even with the softer market, our specialization strategy, the breadth of our specialty offerings, and a strong pipeline keep us positioned to grow through the cycle. So far this year, CRB has delivered 4% organic growth, in line with our full-year expectation of mid-single-digit growth, which we are confident we will achieve. Insurance Consulting and Technology posted 2% organic growth for the quarter. Our technology business saw strong growth on sustained software demand, including Radar, which aligns with our deliberate focus on growing the technology side of the business, while consulting was down as clients postponed discretionary projects. Given the pace of discretionary consulting work, we now expect low single-digit growth for ICT for the full year. Returning to R&B's overall results, the operating margin for the third quarter was 19.8%, up 100 basis points from the prior year, helped by the benefit of book of business settlements along with disciplined expense management. So far this year, R&B's operating margin has expanded 80 basis points; it's worth noting that this result mirrors the normal seasonality of the business. The third quarter is typically our lowest margin quarter of the year, while the fourth quarter is our highest; we remain on track to hit our full-year margin target, with our biggest quarter still ahead of us. Free cash flow for the nine months ended September 30 was $1.064 billion, an increase of $226 million from $838 million in the prior year period. As we look ahead to the fourth quarter, we anticipate organic growth picking up sequentially, driven by specialty activity along with a strong pipeline of new business and renewals. Our outlook for the full year is unchanged: mid-single-digit organic growth and margin expansion of about 100 basis points. Now moving to enterprise-level results, adjusted operating margin in the third quarter was 21.9%, representing 150 basis points of expansion versus the prior year. Excluding the $13 million gain from office building sales, adjusted operating margin rose 100 basis points, reflecting operating leverage and disciplined expense management. That asset sale gain contributed roughly $0.11 to adjusted diluted earnings per share. Lower interest income and a bigger loss from our equity method investment in Willis Re, relative to the prior year, offset that benefit, and the Willis Re result was in line with our expectations. Foreign currency provided a $0.02 tailwind to adjusted EPS this quarter. Based on our current outlook and spot rates, we expect a tailwind of approximately $0.02 in the fourth quarter of 2026, bringing the full-year tailwind to $0.35. Our US GAAP tax rate for the quarter was 19.5% compared with 19.7% a year earlier, and the adjusted tax rate was 21.9% versus 22.4% in the third quarter of 2025; we continue to expect our adjusted tax rate to remain relatively consistent with the prior year. Free cash flow for the 9 months ended September 30 was $1.064 billion, up $226 million from $838 million in the prior year period.
Andrew Krasner
executiveThrough the three quarters closing on September 30th, free cash flow reached $1 billion 64 million — $226 million more than the $838 million posted in the corresponding stretch last year, a figure that counts $29 million gained from office building sales. Operating margin expansion drove most of that year-over-year improvement, and we continue to expect our free cash flow margin to widen across the full year, even as we put money into Propel. Our financial framework for Propel, as Carl noted, remains exactly as before. We anticipate deploying about $625 million in cash to generate roughly $400 million of run-rate savings by the end of 2028, which comes to a cash cost-to-achieve ratio of approximately 1.6. After reinvesting around $50 million into growth, our expectation remains at about $350 million in net run-rate savings and an adjusted operating margin of roughly 30% in 2028. During the third quarter, we recorded approximately $7 million in cash costs and $14 million in noncash charges related to the program. The savings recorded in the quarter were modest, yet the actions completed to date total approximately $18 million in annualized run-rate savings. We anticipate that both investment and savings will begin accelerating significantly in 2027, and those gains should build on each other throughout 2028. In the quarter, we repurchased $220 million in WTW stock and distributed $89 million in quarterly cash dividends. So far this year, we have bought back $970 million in shares, which puts us well on the way toward our $1 billion full-year repurchase target; we plan to continue buying back stock during the fourth quarter and now anticipate that full-year repurchases will come in above $1 billion, depending on market conditions and possible allocation of capital toward organic and inorganic investment opportunities. Our philosophy on capital allocation and M&A has not changed and remains disciplined; we will keep assessing opportunities with care and patience, emphasizing strategic fit and the creation of long-term value. We still have a lot of room to give money back to shareholders as our free cash flow grows. The results for our third quarter show ongoing discipline throughout the company and advancement toward our strategic and financial goals. With that said, let's begin the Q&A.
Mark Hughes
analystThanks so much. Over in the health, wealth, and career segment, there seems to be a slight shift in your organic guidance. Could you expand a bit on what that implies for 4Q and then for the coming year as well?
Carl Hess
executiveMorning, Mark, and thanks for asking. To frame things up, Health, Wealth & Career posted 4% organic revenue growth during the third quarter. Including our Newfront, Cushion, and Flowstone acquisitions, that comes to 7% growth. Continued momentum in Health largely fueled that growth, and Career had a solid quarter for us. Operating margin rose 90 basis points, reaching 29.5%. Operating leverage and ongoing expense discipline were the main drivers there. Our full-year outlook has been adjusted to low to mid-single-digit growth, largely reflecting the implementation timing in BD&O that we've talked about plus the dynamics in Career, though we don't believe underlying demand has shifted. Julie, would you like to share some specifics on HWC?
Julie Gebauer
executiveThanks, Carl. Let me build on a few of the points Andrew made in his prepared remarks and give you the specifics for each of our business groupings. I'll begin with Health. Health posted 6% organic growth, with gains in every region; that came from new business, strong renewals, and project work. Employers of all sizes, mid-market and large market alike, keep coming to us for help with their healthcare and other benefit programs. At the moment, demand centers squarely on managing the very large healthcare cost increases they're up against. Our latest best practices research shows that 78% of employers describe cost control as the most important element of their benefit strategy. With that context in mind, for the full year we continue to anticipate high single-digit growth in Health. Moving on to Wealth, which grew 2% even while we absorbed the hit from US defined benefit plan terminations. That growth was driven by consistent core retirement work, ongoing de-risking activity, new client wins across both investments and retirement, and robust expansion in several newer areas such as personal wealth, pension brokerage, and other defined contribution solutions. We anticipate that continuing, and for the full year we're looking at growth at the top of the low single-digit range for Wealth. Turning next to Career, which grew 9% — or 10% when you exclude the Middle East. Most of that increase came from stronger sales and more compensation survey deliveries. As Andrew mentioned in his prepared remarks, timing played a role as well. A few surveys last year landed in Q4 rather than Q3. Now that we're back on the usual schedule, that helped lift growth in this year's third quarter. Naturally, that timing benefit will reverse itself in the fourth quarter. On top of that, the continued Middle East conflict keeps holding back growth for our Career businesses in that region. Year to date, Career growth stands at 3%. Excluding the Middle East, it would have been 5%. We anticipate that kind of effect will persist, so Career's full-year guidance has been trimmed to low single-digit growth. Last, turning to Benefits Delivery & Outsourcing, which was down 2%. Outsourcing posted modest growth thanks to those new client wins and project work, but that was offset by an expected drop in individual marketplace. As we've reminded you repeatedly, 80% of individual marketplace's annual revenue is recorded in the fourth quarter. All year long, we've expected individual marketplace to grow nicely in Q4, since employers are strongly focused on managing retiree healthcare costs. As a matter of fact, we just went through the best sales cycle we've had in more than ten years—sales that would bring over 100,000 new retirees onto our base of 1.2 million. That said, for reasons unique to each of their organizations, 3 very large clients pushed their implementations back to next year; together, those clients account for 75,000 retirees. Given those delays, and given that those retirees will be coming onto our platform in Q4 of next year instead of this year, we now expect BD&O to be roughly flat for 2026. Let me restate what I just said: those retirees move into 2027, and that comes on top of a pipeline that was already stronger than the one we had when this year began. Perhaps now, having said all that, a recap of our outlook would be useful. Health and Wealth should continue gaining momentum in the fourth quarter. BD&O growth will be constrained by the delayed individual marketplace implementations I mentioned a moment ago. Career growth will feel the effect of the continuing Middle East conflict. Across the segment as a whole, we anticipate low to mid-single-digit growth along with ongoing margin expansion for the full year. The broader forecast for HWC continues to provide solid support for what Carl outlined—mid-single-digit growth for the entire company across the full year, along with incremental margin expansion at HWC in the current year. Looking further ahead, our long-term view of mid-single-digit growth and margin expansion for HWC remains the same.
Mark Hughes
analystThanks for laying all that out, Julie. I did have one question about the CRB. Do you notice any difference in growth between, say, small and middle market accounts on one side and national accounts on the other, when we consider the pricing cycle and perhaps the commission versus fee mix? Is that small-mid versus large split a helpful distinction?
Lucy Clarke
executiveHi, Mark, this is Lucy. On that point, I'd simply say that in the pricing cycle, we do observe a gap between large and complex accounts, which softening rates hit the hardest, and the middle market, which is likely affected less by the softening rate cycle. Thanks.
Elyse Greenspan
analystHello, thank you. First off, I'd like to ask about the capital discussion, is that right? You've raised the buyback so that it's above $1 billion for the year, but you noted that this depends on possible capital allocation, and you mentioned inorganic investment opportunities. I was hoping you might provide an update on the types of inorganic deals you're looking at — size, geographies, that kind of thing? Is it probable that you'll do another transaction soon?
Carl Hess
executiveGood morning, Elyse, and thanks for asking. I'd put it like this, right? Our approach to M&A remains consistent with what we've talked about on earlier calls, and it remains disciplined. We remain in the process of assessing opportunities, and we'll take a thoughtful, patient approach, concentrating on strategic fit and creating long-term value. As a reminder, there are multiple areas in which we still see attractive opportunities. First, we're especially interested in bolt-on acquisitions that align well with the specialty strategy. In the wealth space, which we view as a vast and expanding market, we're particularly interested in wealth management and defined contribution capabilities in growing markets. We'll selectively consider larger opportunities to strengthen our presence in geographies and market segments of interest. My view is this: our data and technology platforms are industry-leading, and last year's Newfront acquisition strengthened them further. We also have a distinctive culture. For any company considering joining us, those assets ought to be genuinely compelling. We seek partners that fit well on culture, allow us to complete a transaction with minimal business disruption, and naturally meet the criteria I just described. Turning to direction: through M&A, we continue to pursue a richer mix of broking in our business. We regard that as a central chance to grow into parts of our business with high growth and high margins. Additionally, there's a chance for us to participate throughout the insurance value chain—such as the reinsurance joint venture with Bain—which can help speed up our growth. Also, regardless of circumstances, any merger involving WTW must present a strong financial case, correct—one that improves our margins and free cash flow profile. I won't address speculative scenarios, right, but I believe that provides a solid sense of our M&A strategy.
Elyse Greenspan
analystThank you. My follow-up, then, concerns R&B organic. I picked up on your comment that organic would speed up in Q4 compared with Q3. Is that confirmation against the 5 reported, or against the 4 ex-book of business gains? And beyond that, could you share a few thoughts about the 2027 outlook for that business too? Let me frame it again.
Carl Hess
executiveIn the quarter, R&B produced 5% organic, 4% ex-book of business and investment income, and that happened even with rates being more challenging. CRB likewise expanded 5% organically, which compares with a 6% comparable a year ago. To me, that demonstrates our specialization strategy and our talent and technology investments are genuinely paying off; that's 4% year to date. With Propel continuing to be implemented, we will build on the solid foundation those investments have already established, and we believe that gives us further opportunities for growth and efficiency as we scale AI and technology capabilities throughout R&B. Those investments, we expect, will add to the roughly 100 basis points of average annual margin expansion we have discussed before, and they underpin our path toward a 30% or plus adjusted operating margin in R&B by 2028. Even in a softer rate environment, the segment's growth and margin trajectory stays strong, and our specialization strategy, the breadth of our specialty offerings, and a strong pipeline keep positioning us to grow well across the cycle. Lucy, would you like to add?
Lucy Clarke
executiveAbsolutely. We posted a strong quarter, particularly considering the comparison we had highlighted with last year's one-time project placements. CRB generated 5% organic growth this quarter, powered by robust results across North America, Asia, and Central and Eastern Europe, Middle East, and Africa. A number of our businesses, GB and Western Europe among them, likewise turned in good performances, especially in light of the effect from certain one-off items we noted during the previous quarter. Our global specialty businesses enjoyed yet another really strong quarter, with strong contributions across nearly every specialty line, though construction, surety, crisis management, and marine deserve particular mention. Our specialization strategy keeps delivering real impact in the market. The teams produced strong new business during the quarter, securing multiyear engagements, notably across digital infrastructure in several of our geographies, all while sustaining high client retention. Within ICT, we keep seeing solid growth, 2% organically in Q3, led by strong growth in our technology business. Consulting revenue, however, fell as clients continue deferring discretionary projects. In view of that pace of work, we now anticipate low single-digit growth for ICT for the full year. Andrew, would you like to comment on the growth numbers?
Andrew Krasner
executiveAbsolutely. With that kind of momentum, we do anticipate organic growth accelerating on a quarter-over-quarter, sequential basis, and Elyse, that would be measured against the figure as reported.
Elyse Greenspan
analystThank you.
Greg Peters
analystMorning, all. On the first question, I'll zero in on Propel; so you've now had this program deploying for a couple of months. Looking at slide 23 and the roadmap you lay out for expected margin improvement through 2028, I'm curious whether you can update us on how the cadence of that margin improvement could shift now that you've got a couple of months of the program behind you?
Andrew Krasner
executiveAbsolutely. Our expectation is that this accumulates gradually. We haven't provided specific guidance for the interim periods when it comes to margin guidance, but we anticipate it building gradually. Even more significant, while we fund investments that come from Propel, well, to produce cost savings, but also reinvesting for growth, we anticipate free cash flow margin expanding in 2026. The financial benefits from Propel ramp up in 2027 and compound into 2028. That is what brings us to the 30% adjusted operating margin target. The foundational work comes first, and then we'll manage savings through both reskilling and other actions, and those take time. Propel's benefits do not end in 2028. Propel makes WTW more competitive, and the benefits will keep coming as our investments wind down, especially as costs subside. In 2029, our free cash flow margin will step up once more, strengthening our ability to return capital to shareholders. On the phasing, Greg, it differs by segment; in Health, Wealth & Career, we anticipate margin improvement building at a fairly even pace across the period. In R&B, we anticipate the benefits being weighted more toward 2028 than 2027. The work there centers on rolling out a new operating model globally, which means the investment and the organizational change come first, and the savings follow once those changes are in place across our various markets.
Greg Peters
analystThank you for that context. I want to shift direction—you gave fairly solid guidance regarding what reinsurance business costs should be this year. Could you perhaps take a step back and walk us through the BMS acquisition, and then, when we consider reinsurance costs flowing through your P&L next year, I'm wondering: does growth in the reinsurance business at BMS alter what we ought to expect on costs for next year?
Carl Hess
executiveLet me begin again, Greg. In our view the JV is moving forward as planned. We're quite pleased with quarterly progress: Neil Eckert's appointment as CEO and the pending purchase of BMS Re, a US reinsurance broking business; the momentum excites us greatly as we keep investing to launch, scale, and newly commercial operations. Lucy, do you have anything else to add on the activity, and perhaps Andrew, you could then speak a bit about financials?
Lucy Clarke
executiveAppreciate that, Carl. Greg, absolutely — we're truly happy about how things are progressing at Willis Re. In London and Bermuda, all of the following are now up and running: global specialty lines, marine, energy, credit, surety, political risk, aviation, and non-marine property. BMS Re is about to close very soon, and it makes us very proud to welcome talent and scale of that magnitude into Willis Re as the basis for our US platform. Our German leader is on board, operations in Europe are underway, and next week our Asia management team begins. By the time '26 closes, we expect to have more than 350 people. Naturally, a benefit of growing this ourselves is having a brand-new location, and construction of our groundbreaking AI-powered technology setup is running ahead of plan, with certain pieces already operational and performing better than we had anticipated. Andrew?
Andrew Krasner
executiveAbsolutely, Lucy. On the associates' earnings line, we booked a loss of $13 million for Q3, and that came in right where we had expected it to. Our guidance still calls for roughly a $0.30 hit to adjusted EPS in '26 stemming from this investment. Looking ahead, we anticipate Willis Re will keep weighing on adjusted EPS next year as we put more money into scaling the platform — and that includes bringing BMS Re's US business into the fold once the deal is completed. And as we always do, we'll share a more detailed outlook for '27 on our fourth quarter earnings call.
Paul Newsome
analystGood morning. Perhaps we could offer a few thoughts by stepping back and examining some of those slower-growing businesses. What I'd like to know is how tightly connected these businesses now are with the rest of your operations — in other words, do wealth and career assist other areas of the business, or would you say they're largely independent of one another when it comes to executing the business?
Carl Hess
executiveLet's begin with BD&O, why don't we? I believe I follow where you're headed with this. Just to remind you, BD&O experienced its strongest sales cycle in a decade, though we pointed out that growth was muted because some large clients pushed implementations into next year. Let me be clear: these are delays in implementation, we already have a great pipeline for next year and this simply adds to it. Even though recent growth has come in below what we'd like, we keep seeing strong demand for the business and we're confident about the underlying opportunity as we go forward. Julie, would you like to speak to fit?
Julie Gebauer
executiveThanks, Carl. Within HWC, I do see BD&O as a very solid strategic fit. These businesses bring together our expertise in benefits, our technology, and our administrative capabilities, which lets us provide essential services to clients while also opening up chances to strengthen those client relationships. Let me point out a few extra things about each piece of BD&O. It covers defined benefit outsourcing, and those services frequently get bundled with our other DB offerings, giving clients a single-source defined benefit answer, and in our view that sets us apart in the marketplace. Those underlying pension administration capabilities are also central to several rapidly expanding areas: LifeSight solutions in Great Britain and Ireland, plus our new pension risk transfer solution in Germany. Along similar lines, a growing number of clients see value in bundling health and benefits broking and advisory together with outsourcing services. What they've discovered is that this didn't just boost efficiency — it also links workforce data with claims data, enabling them to identify improved approaches for producing better outcomes and controlling those costs. Now, on the individual marketplace side, notwithstanding the implementation delays, the growth opportunity there is quite large. Interest from employers keeps rising because group retiree healthcare costs are climbing at double digit, and those programs are turning unworkable. Our estimate is that 12 million retirees remain — bear in mind, our base is 1.2 million — 12 million retirees are covered by group plans that a more affordable set of individual policies, with richer benefits delivered via an individual marketplace, could replace. And past retirees, our market research indicates that a third of US employers will give serious thought to an individual marketplace for their active employees during the coming 3 years. Stepping back for a moment, Paul, you may recall our discussions about how we deliberately built this business around offerings where we felt we could stand out, achieve scale, and produce appealing margins. We've stayed disciplined regarding where we compete. Growth purely for its own sake isn't something we've chased. Profitable revenue growth has been our focus. Although we don't disclose earnings beneath the segment level, I can tell you that BD&O margins sit well above our enterprise margin. I can also tell you that over the last 3 years, BD&O's operating margin has expanded consistently, and at a pace much quicker than HWC's operating margin. In summary, the strategic fit inside HWC is a strong one.
Carl Hess
executiveTo wrap that up, Paul — as Julie has mentioned on earlier calls, we see smart connections throughout the business. Demand remains strong among clients who might be engaged with just one area of health, wealth, or career, yet there's a very natural opportunity to offer them solutions spanning the whole portfolio.
Paul Newsome
analystThat's very clear. For my second question, I'd like to zoom out again — not just next quarter, but over roughly the coming two years. How much do the margin targets hinge on holding onto or growing organic growth? Your peers tend to say that a point or two up or down carries a particular margin consequence, though clearly many other factors are in motion at Willis. Any perspective at that big-picture level would be helpful.
Carl Hess
executivePaul, here's how I'd frame it: in our view we're well placed no matter what the external growth backdrop looks like. Let me explain why. We've noted before that we're set up well to steer through macroeconomic uncertainty. Our performance record is strong across a variety of market conditions. In our view, the present environment also offers meaningful opportunities. As geopolitical and economic disruption intensifies, clients require trusted advice and effective risk management. With clients coming to WTW to work through these challenges, demand for our solutions remains evident. Our conviction in our target isn't tied to any specific macroeconomic result. It rests on the actions within our control, while positioning the company to seize growth opportunities across a variety of external environments.
Mike Zaremski
analystHi, thanks. Good morning. Going back to the R&B segment discussion, could you perhaps break down what's behind the acceleration in book of business revenue sales, and does the guidance for the year include that in 4Q? Thanks.
Andrew Krasner
executiveSure. Producer movement happens normally in our industry and it goes both directions; we keep drawing strong talent, and our client relationships are institutional, backed by deep benches across our specialties. Regarding book of business settlements, a certain amount of that activity is typical in our broking business. This quarter, we had $20 million of book of business settlements, with $18 million in R&B. Even excluding those settlements, we saw solid underlying growth, right, CRB grew 4% excluding book of business settlements and interest income, driven by new business in our specialty lines. I think the level you're seeing here is fairly consistent with the recent past. Nothing we see is atypical.
Mike Zaremski
analystUnderstood. Perhaps if we stay focused on the R&B segment, it's pretty clear regarding the 4Q acceleration anticipated within Risk & Broking. Could you help us break that down a bit? Europe has been a major contributor, yet it has slowed considerably during this year. I believe you mentioned something like low singles excluding the difficult comparison. Should we expect the reacceleration across CRB overall to stem from Europe recovering, or what exactly is behind it? Thanks.
Lucy Clarke
executiveThank you, Mike. Hello, this is Lucy. Certainly. We posted 5% organic growth for the quarter, and I highlighted North America, CEMA, and Asia. Let me just remind you that a portion of what you observed in Europe during this quarter stems from the one-offs we identified in Q3 of last year. Large one-off items affected them in that quarter, but they still delivered a solid result regardless, and we anticipate that growth will pick up in the fourth quarter. Thanks.
Carl Hess
executiveWe appreciate everyone being with us today, and I'd like to express gratitude to our WTW colleagues for their dedication, hard work, and commitment to innovation. Thanks also go to our shareholders for continuing to back what we do. Have a wonderful day, all.
Operator
operatorThat wraps up today’s conference call, everyone. We appreciate you joining us, and you’re welcome to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Willis Towers Watson Public Limited Company transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Willis Towers Watson Public Limited Company earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Willis Towers Watson Public Limited Company or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.